Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review
Abstract Introduction Psoriasis is a systemic inflammatory disease with increased cardiometabolic risk including dyslipidaemia and diabetes. Biologic therapy effectively treats the cutaneous inflammatory burden of psoriasis and evolving evidence suggests potential to reduce systemic inflammatory seq...
Saved in:
Main Authors: | Annika Smith, Aidin Karahasan, Deborah Yi, Sanjay Yapabandara, James Elhindi, Pablo Fernandez-Penas, Clara Chow, Sarah Zaman |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2025-01-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-024-01327-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01) -
Preterm Birth and Cardiometabolic Health Trajectories From Birth to Adulthood: The Avon Longitudinal Study of Parents and Children
by: Gemma L. Clayton, et al.
Published: (2025-02-01) -
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Managing pediatric psoriasis: update on treatments and challenges—a review
by: A. A. Hebert, et al.
Published: (2022-07-01) -
COVID-19 pandemic and vaccination rate in patients with psoriasis treated with biologics: A single center experience
by: Milčić Danijela, et al.
Published: (2024-01-01)